LRRTM3 | Leucine rich repeat transmembrane neuronal 3 | Predicted membrane proteins
| | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | | | | | | Group enriched |
RTL1 | Retrotransposon-like 1 | Predicted membrane proteins
| | | | | Group enriched |
UCP1 | Uncoupling protein 1 (mitochondrial, proton carrier) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CHRNB4 | Cholinergic receptor, nicotinic, beta 4 (neuronal) | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
MGARP | Mitochondria-localized glutamic acid-rich protein | Predicted membrane proteins
| | | | | Tissue enriched |
PABPC1L2B | Poly(A) binding protein, cytoplasmic 1-like 2B | | | | | | Group enriched |
PHOX2B | Paired-like homeobox 2b | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM130 | Transmembrane protein 130 | Predicted membrane proteins
| | | | | Group enriched |
ASIC4 | Acid-sensing (proton-gated) ion channel family member 4 | Predicted membrane proteins
| | | | | Group enriched |
CARTPT | CART prepropeptide | FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
FBLL1 | Fibrillarin-like 1 | | | | | | Group enriched |
NKAIN1 | Na+/K+ transporting ATPase interacting 1 | Predicted membrane proteins
| | | | | Group enriched |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SLC18A1 | Solute carrier family 18 (vesicular monoamine transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
WDR63 | WD repeat domain 63 | | | | | | Group enriched |
ZFR2 | Zinc finger RNA binding protein 2 | | | | | | Group enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
AP000783.1 | Uncharacterized protein | | | | | | Tissue enriched |
AS3MT | Arsenic (+3 oxidation state) methyltransferase | Enzymes
| | | | | Tissue enriched |
CACNA1B | Calcium channel, voltage-dependent, N type, alpha 1B subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CELA1 | Chymotrypsin-like elastase family, member 1 | Enzymes
| | | | | Group enriched |
CHRNA3 | Cholinergic receptor, nicotinic, alpha 3 (neuronal) | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
FRRS1L | Ferric-chelate reductase 1-like | Predicted membrane proteins
| | | | | Group enriched |
KIAA1024 | KIAA1024 | Predicted membrane proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | | | | | | Group enriched |
MAP3K15 | Mitogen-activated protein kinase kinase kinase 15 | Enzymes
| | | | | Tissue enriched |
MCOLN3 | Mucolipin 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
MYT1 | Myelin transcription factor 1 | Plasma proteins Transcription factors
| | | | | Group enriched |
NEUROD4 | Neuronal differentiation 4 | Transcription factors
| | | | | Tissue enriched |
NGB | Neuroglobin | | | | | | Group enriched |
RALYL | RALY RNA binding protein-like | | | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
SPOCK3 | Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | Predicted secreted proteins
| | | | | Group enriched |
CELF3 | CUGBP, Elav-like family member 3 | | | | | | Group enriched |
CLRN1 | Clarin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
COQ10A | Coenzyme Q10 homolog A (S. cerevisiae) | Mitochondrial proteins
| | | | | Group enriched |
DNER | Delta/notch-like EGF repeat containing | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
ELAVL4 | ELAV like neuron-specific RNA binding protein 4 | | | | | | Group enriched |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Group enriched |
FRMD5 | FERM domain containing 5 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
GPR98 | G protein-coupled receptor 98 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
IGLON5 | IgLON family member 5 | Predicted secreted proteins
| | | | | Group enriched |
KCNK2 | Potassium channel, subfamily K, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
NKAIN3 | Na+/K+ transporting ATPase interacting 3 | Predicted membrane proteins
| | | | | Group enriched |
NR0B1 | Nuclear receptor subfamily 0, group B, member 1 | Cancer-related genes Disease related genes Nuclear receptors Plasma proteins Transcription factors
| | | | | Group enriched |
NRCAM | Neuronal cell adhesion molecule | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |